ReP USP - Resultado da busca

Artigo de periodico
6-Nitrodopamine is an endogenous mediator of the rabbit corpus cavernosum relaxation (2024)
Lima, Antonio Tiago Silva ; Britto Junior, José ; Moraes, Manoel Odorico ; Moraes, Maria Elisabete A. ; Fregonesi, Adriano ; Monica, Fabiola Zakia ; Antunes, Edson ; De Nucci, Gilberto
Source: Andrology. Unidade: ICB
Subjects: FARMACOLOGIA, COELHOS, PROTEÍNAS DA MEMBRANA, CANAIS IÔNICOS, RECEPTORES DE DOPAMINA, MÚSCULO LISO VASCULAR, CATECOLAMINAS, CROMATOGRAFIA LÍQUIDA, ESPECTROMETRIA DE MASSAS, PÊNIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Antonio Tiago Silva et al. 6-Nitrodopamine is an endogenous mediator of the rabbit corpus cavernosum relaxation. Andrology, v. 12, n. 6, p. 1419-1428, 2024Tradução . . Disponível em: https://doi.org/10.1111/andr.13585. Acesso em: 06 nov. 2024.
APA
Lima, A. T. S., Britto Junior, J., Moraes, M. O., Moraes, M. E. A., Fregonesi, A., Monica, F. Z., et al. (2024). 6-Nitrodopamine is an endogenous mediator of the rabbit corpus cavernosum relaxation. Andrology, 12( 6), 1419-1428. doi:10.1111/andr.13585
NLM
Lima ATS, Britto Junior J, Moraes MO, Moraes MEA, Fregonesi A, Monica FZ, Antunes E, De Nucci G. 6-Nitrodopamine is an endogenous mediator of the rabbit corpus cavernosum relaxation [Internet]. Andrology. 2024 ; 12( 6): 1419-1428.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1111/andr.13585
Vancouver
Lima ATS, Britto Junior J, Moraes MO, Moraes MEA, Fregonesi A, Monica FZ, Antunes E, De Nucci G. 6-Nitrodopamine is an endogenous mediator of the rabbit corpus cavernosum relaxation [Internet]. Andrology. 2024 ; 12( 6): 1419-1428.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1111/andr.13585
Artigo de periodico
6-Nitrodopamine is a major endogenous modulator of human vas deferens contractility (2022)
Britto Júnior, José ; Silva Filho, Walter Pinto da; Amorim, Amanda Consulin; Campos, Rafael ; Moraes, Manoel Odorico ; Moraes, Maria Elisabete A. ; Fregonesi, Adriano ; Monica, Fabiola Zakia ; Antunes, Edson ; De Nucci, Gilberto
Source: Andrology. Unidade: ICB
Subjects: FARMACOLOGIA, RECEPTORES DE DOPAMINA, ÓXIDO NÍTRICO, ANTIDEPRESSIVOS, CATECOLAMINAS, ADRENÉRGICOS, ADRENORECEPTORES, RATOS, RECEPTORES ADRENÉRGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITTO JÚNIOR, José et al. 6-Nitrodopamine is a major endogenous modulator of human vas deferens contractility. Andrology, 2022Tradução . . Disponível em: https://doi.org/10.1111/andr.13263. Acesso em: 06 nov. 2024.
APA
Britto Júnior, J., Silva Filho, W. P. da, Amorim, A. C., Campos, R., Moraes, M. O., Moraes, M. E. A., et al. (2022). 6-Nitrodopamine is a major endogenous modulator of human vas deferens contractility. Andrology. doi:10.1111/andr.13263
NLM
Britto Júnior J, Silva Filho WP da, Amorim AC, Campos R, Moraes MO, Moraes MEA, Fregonesi A, Monica FZ, Antunes E, De Nucci G. 6-Nitrodopamine is a major endogenous modulator of human vas deferens contractility [Internet]. Andrology. 2022 ;[citado 2024 nov. 06 ] Available from: https://doi.org/10.1111/andr.13263
Vancouver
Britto Júnior J, Silva Filho WP da, Amorim AC, Campos R, Moraes MO, Moraes MEA, Fregonesi A, Monica FZ, Antunes E, De Nucci G. 6-Nitrodopamine is a major endogenous modulator of human vas deferens contractility [Internet]. Andrology. 2022 ;[citado 2024 nov. 06 ] Available from: https://doi.org/10.1111/andr.13263
Artigo de periodico
Feeding pattern, circadian rhythm, and immune function: what do we know about? (2022)
Estanislau, Thiago Barros ; Krüger, Karsten; Rosa Neto, José Cesar ; Padilha, Camila S. ; Gonçalves, Daniela Caetano ; Minuzzi, Luciele Guerra ; Lira, Fabio Santos
Source: Current Pharmaceutical Design. Unidade: ICB
Subjects: BIOLOGIA CELULAR, NUTRIÇÃO, OBESIDADE, ALIMENTAÇÃO, RITMOS BIOLÓGICOS, RITMO CIRCADIANO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESTANISLAU, Thiago Barros et al. Feeding pattern, circadian rhythm, and immune function: what do we know about?. Current Pharmaceutical Design, v. 28, n. 30, p. 2478-2487, 2022Tradução . . Disponível em: https://doi.org/10.2174/1381612828666220729091451. Acesso em: 06 nov. 2024.
APA
Estanislau, T. B., Krüger, K., Rosa Neto, J. C., Padilha, C. S., Gonçalves, D. C., Minuzzi, L. G., & Lira, F. S. (2022). Feeding pattern, circadian rhythm, and immune function: what do we know about? Current Pharmaceutical Design, 28( 30), 2478-2487. doi:10.2174/1381612828666220729091451
NLM
Estanislau TB, Krüger K, Rosa Neto JC, Padilha CS, Gonçalves DC, Minuzzi LG, Lira FS. Feeding pattern, circadian rhythm, and immune function: what do we know about? [Internet]. Current Pharmaceutical Design. 2022 ; 28( 30): 2478-2487.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1381612828666220729091451
Vancouver
Estanislau TB, Krüger K, Rosa Neto JC, Padilha CS, Gonçalves DC, Minuzzi LG, Lira FS. Feeding pattern, circadian rhythm, and immune function: what do we know about? [Internet]. Current Pharmaceutical Design. 2022 ; 28( 30): 2478-2487.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1381612828666220729091451
Artigo de periodico
Stromal Cell-Derived Factor (SDF) 2 and the endoplasmic reticulum stress response of trophoblast cells in gestational Diabetes Mellitus and in vitro hyperglycaemic condition (2021)
Lorenzon, Aline Rodrigues ; Moreli, Jusciele Brogin ; Melo, Rafaela de Macedo; Namba, Felipe Yukio; Staff, Anne Cathrine ; Yung, Hong Wa ; Burton, Graham J.; Bevilacqua, Estela Maris Andrade Forell
Source: Current Vascular Pharmacology. Unidade: ICB
Subjects: BIOLOGIA CELULAR, DIABETES MELLITUS, TROFOBLASTO, PLACENTA, GRAVIDEZ NO DIABETES, HIPERGLICEMIA, TECIDO CONJUNTIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LORENZON, Aline Rodrigues et al. Stromal Cell-Derived Factor (SDF) 2 and the endoplasmic reticulum stress response of trophoblast cells in gestational Diabetes Mellitus and in vitro hyperglycaemic condition. Current Vascular Pharmacology, v. 19, p. 201-209, 2021Tradução . . Disponível em: https://doi.org/10.2174/1570161118666200606222123. Acesso em: 06 nov. 2024.
APA
Lorenzon, A. R., Moreli, J. B., Melo, R. de M., Namba, F. Y., Staff, A. C., Yung, H. W., et al. (2021). Stromal Cell-Derived Factor (SDF) 2 and the endoplasmic reticulum stress response of trophoblast cells in gestational Diabetes Mellitus and in vitro hyperglycaemic condition. Current Vascular Pharmacology, 19, 201-209. doi:10.2174/1570161118666200606222123
NLM
Lorenzon AR, Moreli JB, Melo R de M, Namba FY, Staff AC, Yung HW, Burton GJ, Bevilacqua EMAF. Stromal Cell-Derived Factor (SDF) 2 and the endoplasmic reticulum stress response of trophoblast cells in gestational Diabetes Mellitus and in vitro hyperglycaemic condition [Internet]. Current Vascular Pharmacology. 2021 ; 19 201-209.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1570161118666200606222123
Vancouver
Lorenzon AR, Moreli JB, Melo R de M, Namba FY, Staff AC, Yung HW, Burton GJ, Bevilacqua EMAF. Stromal Cell-Derived Factor (SDF) 2 and the endoplasmic reticulum stress response of trophoblast cells in gestational Diabetes Mellitus and in vitro hyperglycaemic condition [Internet]. Current Vascular Pharmacology. 2021 ; 19 201-209.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1570161118666200606222123
Artigo de periodico-carta/editorial
Immunometabolism disorders: pharmacologic and nonpharmacologic approaches (2020)
Lira, F. S.; Rosa Neto, José Cesar
Source: Current Pharmaceutical Design. Unidade: ICB
Subjects: BIOLOGIA CELULAR, METABOLISMO, DOENÇAS METABÓLICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIRA, F. S. e ROSA NETO, José Cesar. Immunometabolism disorders: pharmacologic and nonpharmacologic approaches. Current Pharmaceutical Design. Sharjah: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/138161282609200423142125. Acesso em: 06 nov. 2024. , 2020
APA
Lira, F. S., & Rosa Neto, J. C. (2020). Immunometabolism disorders: pharmacologic and nonpharmacologic approaches. Current Pharmaceutical Design. Sharjah: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.2174/138161282609200423142125
NLM
Lira FS, Rosa Neto JC. Immunometabolism disorders: pharmacologic and nonpharmacologic approaches [Internet]. Current Pharmaceutical Design. 2020 ; 26( 9): 905.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/138161282609200423142125
Vancouver
Lira FS, Rosa Neto JC. Immunometabolism disorders: pharmacologic and nonpharmacologic approaches [Internet]. Current Pharmaceutical Design. 2020 ; 26( 9): 905.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/138161282609200423142125
Artigo de periodico
Novel [6]-gingerol triazole derivatives and their antiproliferative potential against tumor cells (2020)
Silva, William Cezar de Lima; Conti, Raphael; Almeida, Larissa Costa de ; Morais, Pedro Alves Bezerra ; Borges, Keyller Bastos ; Lacerda Júnior, Valdemar ; Costa-Lotufo, Letícia Veras ; Borges, Warley de Souza
Source: Current Topics in Medicinal Chemistry. Unidade: ICB
Subjects: FARMACOLOGIA, PRODUTOS NATURAIS, PLANTAS MEDICINAIS, GENGIBRE, NEOPLASIAS DO COLON, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS, TERAPÊUTICA, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, William Cezar de Lima et al. Novel [6]-gingerol triazole derivatives and their antiproliferative potential against tumor cells. Current Topics in Medicinal Chemistry, v. 20, n. 2, p. 161-169, 2020Tradução . . Disponível em: https://doi.org/10.2174/1568026620666191227125507. Acesso em: 06 nov. 2024.
APA
Silva, W. C. de L., Conti, R., Almeida, L. C. de, Morais, P. A. B., Borges, K. B., Lacerda Júnior, V., et al. (2020). Novel [6]-gingerol triazole derivatives and their antiproliferative potential against tumor cells. Current Topics in Medicinal Chemistry, 20( 2), 161-169. doi:10.2174/1568026620666191227125507
NLM
Silva WC de L, Conti R, Almeida LC de, Morais PAB, Borges KB, Lacerda Júnior V, Costa-Lotufo LV, Borges W de S. Novel [6]-gingerol triazole derivatives and their antiproliferative potential against tumor cells [Internet]. Current Topics in Medicinal Chemistry. 2020 ; 20( 2): 161-169.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1568026620666191227125507
Vancouver
Silva WC de L, Conti R, Almeida LC de, Morais PAB, Borges KB, Lacerda Júnior V, Costa-Lotufo LV, Borges W de S. Novel [6]-gingerol triazole derivatives and their antiproliferative potential against tumor cells [Internet]. Current Topics in Medicinal Chemistry. 2020 ; 20( 2): 161-169.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1568026620666191227125507
Artigo de periodico
Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction (2020)
Paulo, Michele ; Costa, Daniela E. F. R.; Bonaventura, Daniella; Lunardi, Claure N.; Bendhack, Lusiane Maria
Source: Current Pharmaceutical Design. Unidades: FCFRP, ICB
Subjects: CÉLULAS ENDOTELIAIS, ENDOTÉLIO VASCULAR, ÓXIDO NÍTRICO, FARMACOLOGIA, DOENÇAS VASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAULO, Michele et al. Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction. Current Pharmaceutical Design, v. 26, n. 30, p. 3748-3759, 2020Tradução . . Disponível em: https://doi.org/10.2174/1381612826666200519114442. Acesso em: 06 nov. 2024.
APA
Paulo, M., Costa, D. E. F. R., Bonaventura, D., Lunardi, C. N., & Bendhack, L. M. (2020). Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction. Current Pharmaceutical Design, 26( 30), 3748-3759. doi:10.2174/1381612826666200519114442
NLM
Paulo M, Costa DEFR, Bonaventura D, Lunardi CN, Bendhack LM. Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction [Internet]. Current Pharmaceutical Design. 2020 ; 26( 30): 3748-3759.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1381612826666200519114442
Vancouver
Paulo M, Costa DEFR, Bonaventura D, Lunardi CN, Bendhack LM. Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction [Internet]. Current Pharmaceutical Design. 2020 ; 26( 30): 3748-3759.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1381612826666200519114442
Artigo de periodico
Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells (2018)
Fernandes, Thais Batista; Azevedo, Ricardo Alexandre de; Yang, Rosania; Teixeira, Sarah Fernandes; Trossini, Gustavo Henrique Goulart ; Barbuto, José Alexandre Marzagão ; Ferreira, Adilson Kleber; Parise Filho, Roberto
Source: Letters in Drug Design and Discovery. Unidades: FCF, ICB
Subjects: APOPTOSE, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Thais Batista et al. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells. Letters in Drug Design and Discovery, v. 15, n. 12, p. 1288-1298, 2018Tradução . . Disponível em: https://doi.org/10.2174/1570180815666180321161513. Acesso em: 06 nov. 2024.
APA
Fernandes, T. B., Azevedo, R. A. de, Yang, R., Teixeira, S. F., Trossini, G. H. G., Barbuto, J. A. M., et al. (2018). Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells. Letters in Drug Design and Discovery, 15( 12), 1288-1298. doi:10.2174/1570180815666180321161513
NLM
Fernandes TB, Azevedo RA de, Yang R, Teixeira SF, Trossini GHG, Barbuto JAM, Ferreira AK, Parise Filho R. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells [Internet]. Letters in Drug Design and Discovery. 2018 ; 15( 12): 1288-1298.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1570180815666180321161513
Vancouver
Fernandes TB, Azevedo RA de, Yang R, Teixeira SF, Trossini GHG, Barbuto JAM, Ferreira AK, Parise Filho R. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells [Internet]. Letters in Drug Design and Discovery. 2018 ; 15( 12): 1288-1298.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1570180815666180321161513
Artigo de periodico
Edelfosine: an antitumor drug prototype (2018)
Teixeira, Sarah Fernandes ; Rodrigues, Cecília Pessoa ; Costa, Cícero Júlio Silva ; Pettinati, Thais Narimatsu; Azevedo, Ricardo Alexandre de ; Mambelli, Lisley Inata; Jorge, Salomão Dória; Ramos, Rodrigo Nalio; Ferro, Emer Suavinho ; Barbuto, José Alexandre Marzagão ; Ferreira, Adilson Kleber
Source: Anti-Cancer Agents in Medicinal Chemistry. Unidades: ICB, FCF
Subjects: FARMACOLOGIA, IMUNOLOGIA, QUIMIOTERÁPICOS, NEOPLASIAS PULMONARES, SISTEMA IMUNE, FOSFOLIPÍDEOS, PACIENTES, CITOMETRIA DE FLUXO, CITOTOXICIDADE IMUNOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Sarah Fernandes et al. Edelfosine: an antitumor drug prototype. Anti-Cancer Agents in Medicinal Chemistry, v. 18, n. 6, p. 865-874, 2018Tradução . . Disponível em: https://doi.org/10.2174/1871520618666180105165431. Acesso em: 06 nov. 2024.
APA
Teixeira, S. F., Rodrigues, C. P., Costa, C. J. S., Pettinati, T. N., Azevedo, R. A. de, Mambelli, L. I., et al. (2018). Edelfosine: an antitumor drug prototype. Anti-Cancer Agents in Medicinal Chemistry, 18( 6), 865-874. doi:10.2174/1871520618666180105165431
NLM
Teixeira SF, Rodrigues CP, Costa CJS, Pettinati TN, Azevedo RA de, Mambelli LI, Jorge SD, Ramos RN, Ferro ES, Barbuto JAM, Ferreira AK. Edelfosine: an antitumor drug prototype [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2018 ; 18( 6): 865-874.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1871520618666180105165431
Vancouver
Teixeira SF, Rodrigues CP, Costa CJS, Pettinati TN, Azevedo RA de, Mambelli LI, Jorge SD, Ramos RN, Ferro ES, Barbuto JAM, Ferreira AK. Edelfosine: an antitumor drug prototype [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2018 ; 18( 6): 865-874.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1871520618666180105165431
Artigo de periodico
Advances and challenges in drug design of PPARδ ligands (2018)
Maltarollo, Vinícius Gonçalves ; Kronenberger, Thales ; Windshuegel, Bjoern ; Wrenger, Carsten ; Trossini, Gustavo Henrique Goulart ; Honório, Káthia Maria
Source: Current Drug Targets. Unidades: ICB, FCF, EACH
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, SÍNDROME X METABÓLICA, ÁCIDOS GRAXOS, DOENÇAS METABÓLICAS, PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinícius Gonçalves et al. Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, v. 19, n. 2, p. 144-154, 2018Tradução . . Disponível em: https://doi.org/10.2174/1389450118666170414113159. Acesso em: 06 nov. 2024.
APA
Maltarollo, V. G., Kronenberger, T., Windshuegel, B., Wrenger, C., Trossini, G. H. G., & Honório, K. M. (2018). Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, 19( 2), 144-154. doi:10.2174/1389450118666170414113159
NLM
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Vancouver
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2024 nov. 06 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Parte de monografia/livro
The role of pest degron for targeting caspases substrates to the ubiquitin-proteasome system (2013)
Belizario, Jose Ernesto ; Alves, Juliano; Garay-Malpartida, Humberto Miguel ; Occhiucci, João M.
Source: Advances in protein and peptide sicences. Unidade: ICB
Subjects: PROTEINAS, PEPTIDEOS, APOPTOSE, CICLO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BELIZARIO, Jose Ernesto et al. The role of pest degron for targeting caspases substrates to the ubiquitin-proteasome system. Advances in protein and peptide sicences. Tradução . Sharjah: Bentham Science Publishers, 2013. p. 222-255. Disponível em: http://eurekaselect.com/117181/chapter/the-role-of-pest-degron-for-targeting-caspases-substrates-to-the-ubiquitin-proteasome-syste. Acesso em: 06 nov. 2024.
APA
Belizario, J. E., Alves, J., Garay-Malpartida, H. M., & Occhiucci, J. M. (2013). The role of pest degron for targeting caspases substrates to the ubiquitin-proteasome system. In Advances in protein and peptide sicences (p. 222-255). Sharjah: Bentham Science Publishers. Recuperado de http://eurekaselect.com/117181/chapter/the-role-of-pest-degron-for-targeting-caspases-substrates-to-the-ubiquitin-proteasome-syste
NLM
Belizario JE, Alves J, Garay-Malpartida HM, Occhiucci JM. The role of pest degron for targeting caspases substrates to the ubiquitin-proteasome system [Internet]. In: Advances in protein and peptide sicences. Sharjah: Bentham Science Publishers; 2013. p. 222-255.[citado 2024 nov. 06 ] Available from: http://eurekaselect.com/117181/chapter/the-role-of-pest-degron-for-targeting-caspases-substrates-to-the-ubiquitin-proteasome-syste
Vancouver
Belizario JE, Alves J, Garay-Malpartida HM, Occhiucci JM. The role of pest degron for targeting caspases substrates to the ubiquitin-proteasome system [Internet]. In: Advances in protein and peptide sicences. Sharjah: Bentham Science Publishers; 2013. p. 222-255.[citado 2024 nov. 06 ] Available from: http://eurekaselect.com/117181/chapter/the-role-of-pest-degron-for-targeting-caspases-substrates-to-the-ubiquitin-proteasome-syste
Artigo de periodico
Origins and evolution of antigenic diversity in malaria parasites (2007)
Ferreira, Marcelo Urbano ; Zilversmit, Martine; Wunderlich, Gerhard
Source: Current Molecular Medicine. Unidade: ICB
Assunto: PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Marcelo Urbano e ZILVERSMIT, Martine e WUNDERLICH, Gerhard. Origins and evolution of antigenic diversity in malaria parasites. Current Molecular Medicine, v. 7, n. 6, p. 588-602, 2007Tradução . . Acesso em: 06 nov. 2024.
APA
Ferreira, M. U., Zilversmit, M., & Wunderlich, G. (2007). Origins and evolution of antigenic diversity in malaria parasites. Current Molecular Medicine, 7( 6), 588-602.
NLM
Ferreira MU, Zilversmit M, Wunderlich G. Origins and evolution of antigenic diversity in malaria parasites. Current Molecular Medicine. 2007 ; 7( 6): 588-602.[citado 2024 nov. 06 ]
Vancouver
Ferreira MU, Zilversmit M, Wunderlich G. Origins and evolution of antigenic diversity in malaria parasites. Current Molecular Medicine. 2007 ; 7( 6): 588-602.[citado 2024 nov. 06 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration